https://orcid.org/0000-0001-9971-9485
Figures & data
Figure 1. HD attrition flowchart. HD, Huntington’s disease.
Table 1. Participant characteristics by HD stage at baseline.
Table 2. Any all-cause HRU within 6-months post-index by baseline HD stage.
Figure 2. Mean all-cause HRU PPPM by post-index HD stage. The non-parametric Friedman test was used for comparing the three HD stages. Individuals can contribute person-time and HRU to each category based on stages in follow-up. Outpatient visits, inpatient visits, ER visits, and pharmacy visits are mutually exclusive. HD-related pharmacy claims are a subset of pharmacy claims. Radiology and PT/OT procedures are subsets of inpatient and outpatient visits. ER, emergency room; HD, Huntington’s disease; HRU, healthcare resource utilization; PPPM, per patient per month; PT, physical therapy; OT, occupational therapy.
Figure 3. Mean all-cause healthcare costs PPPM (2018 USD) by post-index HD stage. Individuals can contribute person-time and HRU to each category based on stages in follow-up. Outpatient costs, inpatient costs, and pharmacy costs are mutually exclusive. HD-related pharmacy claims are a subset of pharmacy costs. Long-term care/nursing and skilled nursing facility are subsets of inpatient and outpatient costs. HD, Huntington’s disease; PPPM, per patient per month; SNF, skilled nursing facility.
